Exicure Inc R&D Day - Virtual Transcript
Hi, everybody, and welcome to Exicure's R&D Day. My name is David Giljohann, I'm the CEO of Exicure. And on behalf of the entire Exicure team and our guests today, thank you for joining us as we discuss how Exicure is building a leading platform in neurology and working to bring that platform into patients as fast as possible.
A couple of notes as we get started. We are a publicly traded company out of the ticker symbol XCUR. As such, we refer to -- you to our SEC guidance regarding forward-looking statements and nonsolicitation.
We have a dynamic group of speakers ready to go for today. In addition to myself, we have Matthias Schroff, our Chief Operating Officer; Doug Feltner, our Chief Medical Officer; Susan Perlman, a Clinical Professor of Neurology at UCLA; Jen Farmer from FARA; and our program managers for Neuro, Grant Corbett and Bart Anderson.
We're very pleased today to have Dr. Susan Perlman joining us. Susan Perlman is a Clinical Professor of Neurology
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |